INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines - DOCS

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

PRNewsWire • 10 hours ago

DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law

LOS ANGELES, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. (“Doximity” or “the Company”) (NYSE: DOCS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of DOCS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

GlobeNewsWire • 9 hours ago

Doximity, Inc. Class Action Reminder – Robbins LLP Encourages DOCS Investors to Contact the Firm for Information About Their Rights

The complaint alleges that Doximity failed to disclose it was losing market share to its competitors with more favorable pricing and engagement models.

GlobeNewsWire • 9 hours ago

Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Doximity (DOCS) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 11/16/2026

GlobeNewsWire • 7 hours ago

DOCS DEADLINE: SueWallSt Reminds Doximity, Inc. Investors of Upcoming Securities Class Action Deadline

Doximity's CEO and former CFO are named as alleged controlling persons in a securities class action claiming the Company overstated how much its "Newsfeed" product drove revenue growth while allegedly losing market share to competitors. NEW YORK, Oct. 29, 2026 /PRNewswire/ -- SueWallSt alerts investors in Doximity, Inc. (NYSE: DOCS) that a securities class action has been filed on behalf of shareholders who purchased common stock between August 8, 2024 and May 13, 2026.

PRNewsWire • 10 hours ago

What's Next for Doximity, Inc. Shareholders After 23% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline

Complaint alleges Doximity, Inc. misled investors between August 8, 2024 and May 13, 2026; investors may seek lead plaintiff role by November 16, 2026 LOS ANGELES, Oct. 29, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP ("Glancy") announced today that the class action lawsuit covers investors who bought Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS) securities between August 8, 2024 and May 13, 2026. The Doximity, Inc. case, Michigan Laborers' Pension Fund v.

PRNewsWire • 4 hours ago

Kaplan Fox Announces the Lead Plaintiff Deadline of November 16, 2026 in the Securities Class Action Against Doximity, Inc. (DOCS)

New York, New York--(Newsfile Corp. - October 29, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS) on behalf of investors that purchased or otherwise acquired Doximity common stock between August 8, 2024 and May 13, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Doximity and have suffered losses, you may CLICK HERE to contact us.

Newsfile Corp • 16 minutes ago

Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Note

Doximity (DOCS) closed the most recent trading day at $33.63, moving 1.81% from the previous trading session.

Zacks Investment Research • 29 minutes ago

Doximity Launches DoseCheck to Catch Dangerous AI Drug Dosing Errors Before They Reach Doctors

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, has launched DoseCheck, a free additional safety layer in Doximity Ask that instantly checks every AI-generated medication dosing claim against a structured drug database to reduce treatment errors and increase patient safety. The probabilistic nature of AI means that it predicts the most likely answer based on the data it's been trained on. This can lead to different but eq.

Business Wire • 11 hours ago

Deadline Alert: Doximity, Inc. Investors Have Until November 16, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds Investors

Class action covers investors who bought Doximity, Inc. securities between August 8, 2024 and May 13, 2026; complaint alleges the company failed to disclose material adverse facts Class action covers investors who bought Doximity, Inc. securities between August 8, 2024 and May 13, 2026; complaint alleges the company failed to disclose material adverse facts

GlobeNewsWire • Oct 28, 2026